(Q39652181)

13 September 2017

Comparison of ventricular and intravenous lentiviral-mediated gene therapy for murine MPS VII. (English)

1 reference

13 September 2017

0 references

Julie Bielicki

1

1 reference

PubMed ID

20864369

13 September 2017

Chantelle McIntyre

series ordinal

2

1 reference

PubMed ID

20864369

13 September 2017

Donald S Anson

series ordinal

3

1 reference

13 September 2017

17 August 2010

1 reference

Molecular Genetics and Metabolism

13 September 2017

1 reference

13 September 2017

101

1 reference

13 September 2017

4

1 reference

13 September 2017

370-382

1 reference

Prevalence of lysosomal storage disorders

13 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Treatment of lysosomal storage disorders : progress with enzyme replacement therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

The controversial and changing role of haematopoietic cell transplantation for lysosomal storage disorders: an update

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Widespread correction of lysosomal storage following intrahepatic injection of a recombinant adeno-associated virus in the adult MPS VII mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Lentiviral-mediated gene therapy for murine mucopolysaccharidosis type IIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Overcoming the blood-brain barrier with high-dose enzyme replacement therapy in murine mucopolysaccharidosis VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Developmentally regulated mannose 6-phosphate receptor-mediated transport of a lysosomal enzyme across the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Epinephrine enhances lysosomal enzyme delivery across the blood brain barrier by up-regulation of the mannose 6-phosphate receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Intracranial injection of recombinant adeno-associated virus improves cognitive function in a murine model of mucopolysaccharidosis type VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Clearance of albumin from mouse subarachnoid space: a measure of CSF bulk flow

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Supratentorial cerebrospinal fluid production rate in healthy adults: quantification with two-dimensional cine phase-contrast MR imaging with high temporal and spatial resolution.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Regulation of cerebrospinal fluid production by caffeine consumption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Reduced cerebrospinal fluid production and intracranial pressure in mice lacking choroid plexus water channel Aquaporin-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Evidence for bulk flow of brain interstitial fluid: significance for physiology and pathology

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Functional correction of CNS lesions in an MPS-IIIA mouse model by intracerebral AAV-mediated delivery of sulfamidase and SUMF1 genes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Targeted nonviral delivery vehicles to neural progenitor cells in the mouse subventricular zone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Single-dose intracerebroventricular administration of galactocerebrosidase improves survival in a mouse model of globoid cell leukodystrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of beta-glucuronidase-defici

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Widespread gene delivery and structure-specific patterns of expression in the brain after intraventricular injections of neonatal mice with an adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Rational development of a HIV‐1 gene therapy vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Optimisation of a multipartite human immunodeficiency virus based vector system; control of virus infectivity and large-scale production

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Studies on glucosaminidase. 4. The fluorimetric assay of N-acetyl-beta-glucosaminidase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

New method for quantitative determination of uronic acids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

High-resolution electrophoresis of urinary glycosaminoglycans: an improved screening test for the mucopolysaccharidoses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

A rapid sensitive silver stain for polypeptides in polyacrylamide gels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Lentiviral-mediated gene correction of mucopolysaccharidosis type IIIA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Murine mucopolysaccharidosis type VII: the impact of therapies on the clinical course and pathology in a murine model of lysosomal storage disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Gene therapy for murine mucopolysaccharidosis type VII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Murine mucopolysaccharidosis type VII: long term therapeutic effects of enzyme replacement and enzyme replacement followed by bone marrow transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Eosinophilic crystalline pneumonia as a major cause of death in 129S4/SvJae mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Long-term and significant correction of brain lesions in adult mucopolysaccharidosis type VII mice using recombinant AAV vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

A single injection of an adeno-associated virus vector into nuclei with divergent connections results in widespread vector distribution in the brain and global correction of a neurogenetic disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Expression in blood cells may contribute to biochemical and pathological improvements after neonatal intravenous gene therapy for mucopolysaccharidosis VII in dogs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Humanization of anti-human insulin receptor antibody for drug targeting across the human blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Prevention of systemic clinical disease in MPS VII mice following AAV-mediated neonatal gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Enhanced secretion and uptake of beta-glucuronidase improves adeno-associated viral-mediated gene therapy of mucopolysaccharidosis type VII mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

PEGylation of a vesicular stomatitis virus G pseudotyped lentivirus vector prevents inactivation in serum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Selective depletion or blockade of Kupffer cells leads to enhanced and prolonged hepatic transgene expression using high-capacity adenoviral vectors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Treatment of lysosomal storage disease in MPS VII mice using a recombinant adeno-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Correction of murine mucopolysaccharidosis VII by a human beta-glucuronidase transgene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Ultrastructure of the orbital pathway for cerebrospinal fluid drainage in rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Intravitreal gene therapy reduces lysosomal storage in specific areas of the CNS in mucopolysaccharidosis VII mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Elimination of lysosomal storage in brains of MPS VII mice treated by intrathecal administration of an adeno-associated virus vector

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

Targeted delivery of proteins across the blood-brain barrier

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMGME.2010.08.013

10.1016/J.YMGME.2010.08.013

7 January 2021

Identifiers

DOI

1 reference

13 September 2017

1 reference

PubMed ID

20864369